PlainRecalls
FDA Drug Critical Class I Terminated

ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by Teva Parenteral Medicines, Inc., Irvine, CA. NDC 073-3019-11 (individual vial), NDC 0703-3019-12 (carton of five).

Reported: September 2, 2015 Initiated: July 24, 2015 #D-1351-2015

Product Description

ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by Teva Parenteral Medicines, Inc., Irvine, CA. NDC 073-3019-11 (individual vial), NDC 0703-3019-12 (carton of five).

Reason for Recall

Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
6001 vials
Distribution
Nationwide.
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
ADRUCIL (fluorouracil injection, USP), 5 g/100 mL (50 mg/mL) glass vials, 5 x 100 ml vials per carton, manufactured by Teva Parenteral Medicines, Inc., Irvine, CA. NDC 073-3019-11 (individual vial), NDC 0703-3019-12 (carton of five).. Recalled by Teva Pharmaceuticals USA. Units affected: 6001 vials.
Why was this product recalled?
Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution
Which agency issued this recall?
This recall was issued by the FDA Drug on September 2, 2015. Severity: Critical. Recall number: D-1351-2015.